Table 1 Demographic, clinical, laboratory and radiographic characteristics of enrolled AS patients
Characteristics | Mean (SD) or frequencies (percentages) | Range |
|---|---|---|
Age (years) | 36.2 (10.9) | 17–66 |
Male patients, n (%) | 223 (91) | Â |
Age at onset (years) | 24.7 (8.7) | 8–57 |
Disease duration (years) | 11.4 (8.0) | 0–39 |
Overall pain VAS (0-10 cm) | 3.8 (2.3) | 0–10 |
Fatigue VAS (0-10 cm) | 4.1 (2.4) | 0–10 |
Morning stiffness (degree) VAS (0-10 cm) | 3.8 (2.9) | 0–10 |
Morning stiffness (duration) (0-120 min) | 36.7 (32.9) | 0–120 |
ODI (%) (0–100) | 31.8 (19.7) | 0–94 |
Peripheral arthritis, n (%) | 109 (44) | Â |
NSAIDs intake, n (%) | 156 (64) | Â |
Anti-TNF drugs intake, n (%) | 19 (8) | Â |
ESR (mm/h) | 27.0 (19.1) | 2–126 |
CRP (mg/L) | 24.7 (20.6) | 0.2–128.4 |
HLA-B27+, n (%) | 226 (92) | Â |
GK (degrees) | 61.0 (18.7) | 22–122 |
BASDAI (0–10) | 3.5 (2.0) | 0–9 |
BASFI (0–10) | 3.2 (2.6) | 0–10 |
BASMI (0–10) | 4.6 (3.1) | 0–10 |
BAS-G (0–10) | 5.0 (2.6) | 0–10 |